A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma
Clinical trial NCT05451810 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05451810
- Sponsor
- Genmab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-17
- Primary completion
- 2027-03-01
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.